Find Academic Supervisors

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +3 more

Dr. Rebecca San Gil is a Lecturer at the School of Medical Sciences , University of Sydney, Australia. She leads the NeuroMolecular Discovery Group within the Neuroscience theme and is a member of the Charles Perkins Centre . Her research focuses on the molecular mechanisms underlying neurodegenerative diseases such as motor neuron disease (MND) and frontotemporal dementia (FTD) , with an emphasis on protein aggregation, stress responses, and therapeutic discovery. PhD, University of Wollongong (2018) Postdoctoral Research, Queensland Brain Institute (2018–2025) Endeavour Research Fellow (University College London) Her research spans molecular biology , neurosciences , and biochemistry , integrating techniques like genome-wide CRISPR screening , multi-omics analysis , and translational research . Key themes include the role of molecular chaperones , heat shock response , and protein folding dynamics in mitigating neurodegeneration. Dr. San Gil’s recent publications (2016–2025) highlight her work on TDP-43 pathology , heat shock proteins , and therapeutic strategies across ALS/FTD models. She has received awards such as the FightMND Early Career Research Fellow and the Sydney Dementia Network Future Research Leader Award (Travel Support Scheme) in 2025. Scientific Awards : FightMND Early Career Research Fellow, Sydney Dementia Network Future Research Leader Award (2025) Dr. San Gil actively mentors researchers like Celine CHYE and collaborates with institutions globally. Her team welcomes new members to explore neurodegenerative disease biology and therapeutic discovery .

• Neurodegenerative Diseases
• Motor Neuron Disease (MND)
• Frontotemporal Dementia (FTD)
• +7 more

Sonia Mayoral is the Robert J. and Nancy D. Carney Assistant Professor of Neuroscience at Brown University. Her research focuses on studying cell-cell interactions in the brain, particularly the development and function of oligodendrocytes – glial cells critical for myelin formation. She explores how these cells contribute to myelination, remyelination processes, and their roles in neurological disorders like multiple sclerosis. Her work integrates cellular neuroscience, immunology, and drug screening methodologies. Research interests include glial cell biology, neuron-glial interactions, and the molecular mechanisms governing myelin repair. She investigates how environmental cues and signaling pathways regulate oligodendrocyte differentiation and function. Notable projects involve developing high-throughput screening platforms for MS therapeutics and studying sex-specific responses to neurodegenerative challenges. Her lab’s recent work includes clinical trials (Re-WRAP) evaluating Bazedoxifene for remyelination in women, and fundamental studies on regulatory T cell roles in myelin regeneration. She also examines how mechanical stimulation and epigenetic changes influence oligodendrocyte behavior. Her research bridges basic science and translational efforts, aiming to advance treatments for myelin-related disorders. Dr. Mayoral’s lab is active at Brown University, with a dedicated website detailing ongoing projects and collaborations. While no specific grants or students are listed here, her work reflects a strong focus on interdisciplinary approaches to neurodegenerative disease mechanisms.

• Glial Cell Biology
• Myelin
• Neuron-Glia Interactions
• +3 more

Yukiko Gotoh is a Professor at the Department of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo. She serves as the Deputy Director and Principal Investigator at the International Research Center for Neurointelligence (IRCN). Her research focuses on understanding the mechanisms that regulate neural stem/progenitor cell fate during embryonic brain development and in the adult brain. Dr. Gotoh's research interests include: Genetic and epigenetic regulation of neural stem/progenitor cell fate Neuronal maturation processes Genesis and maintenance of adult neural stem cells Relevance of neural stem/progenitor cell dysregulation in neurodevelopmental disorders such as autism spectrum disorders Investigation of mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation Analysis of Dr. Gotoh's recent publications reveals a strong focus on neural stem cell biology, epigenetic regulation, and neurodevelopmental disorders. Her work demonstrates how chromatin modifiers like Polycomb group proteins and HMGA proteins regulate neural stem cell fate decisions during brain development. A significant portion of her research explores the embryonic origins of adult neural stem cells and how dysregulation of these processes contributes to conditions like autism spectrum disorders and schizophrenia. Her laboratory also investigates the basic mechanisms of cellular responses to viral infection in the brain and their relevance to neurodevelopmental disorders. Dr. Gotoh has made significant contributions to understanding: The role of Polycomb group proteins in neural development How chromatin modifiers regulate neurogenic potential Cell cycle regulation in neural stem cells The PDK1-Akt pathway in neuronal migration Layer-specific heterogeneity of astrocytes Mechanisms underlying schizophrenia-related abnormalities Dr. Gotoh's laboratory conducts research on multiple fronts related to neural development and stem cell biology. Her team investigates: Mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation The embryonic origin of adult neural stem cells Dysregulation of neural stem-progenitor cell and neuronal fate in neurodevelopmental disorders Innate immune responses in the brain

• Neural Development
• Neural Stem/Progenitor Cells
• Epigenetics
• +7 more

Anna G Orr serves as Nan and Stephen Swid Assistant Professor of Frontotemporal Dementia Research and Assistant Professor of Neuroscience at Weill Cornell Medical College's Brain and Mind Research Institute since 2016, leading pioneering research on astrocyte biology in dementia pathogenesis. Her educational background includes: Ph.D. from Emory University (2008) B.S. from Allegheny College (2002) Dr. Orr's research program centers on astrocytic-neuronal interactions , mitochondrial signaling , and neuroimmune mechanisms through three interconnected pathways: neuroimmune , oxidative , and G protein-coupled signaling . Her lab investigates how these mechanisms influence neuroinflammation, protein aggregation, synaptic function, and behavioral outcomes in dementia, with parallel therapeutic discovery efforts targeting astrocytic pathways for novel dementia treatments. Analysis of her 15 most recent publications (2025-2010) reveals escalating focus on astrocyte-specific dementia mechanisms , particularly mitochondrial ROS signaling, sex-dimorphic memory effects, TDP-43 pathology interactions with antiviral pathways, and lipid dysregulation in neurodegeneration. Her work consistently bridges molecular discoveries with therapeutic applications, demonstrating increasing NIH funding support for translational approaches. Key scientific recognitions include: NIH K99/R00 Pathway to Independence Award (2017) Leon Levy Fellowship in Neuroscience (2021) Nan and Stephen Swid Endowed Professorship (2021) Outstanding Neuroscience Teaching Award (2021) Dr. Orr actively mentors eight trainees across career stages, including Ph.D. candidates Evelyn Hardin and Constance Zhou, while securing major NIH grants as Principal Investigator for projects like Uncovering Dementia-Related Lipid Alterations in Astrocytes (NIA 2024-2026) and Mitochondrial Complex III Free Radicals in Dementia Pathology (NIA 2020-2026), alongside collaborative awards from the Alzheimer's Association. Her Orr Lab maintains a dual focus on mechanistic astrocyte biology and therapeutic translation, with current projects examining astrocytic TDP-43 dysregulation, mitochondrial complex III signaling, and sex-specific memory mechanisms using advanced in vivo techniques and disease models.

• Neuroscience
• Neurodegenerative Diseases
• Astrocyte Biology
• +5 more

Associate Professor Ian Johnston is affiliated with the School of Psychology at The University of Sydney. His research focuses on neurocognitive effects of medical treatments, pain management, and behavioral interventions. Notable projects include investigations into chemotherapy-induced cognitive impairments and the psychological impacts of high-fat diets. He has contributed to systematic reviews and guidelines for harmonizing preclinical cancer research. Selected grants include a 2022 study on lifelong neurocognitive effects of adolescent diets and a 2020 grant funded by the Boyd Mervin Wilson bequest. His work spans interdisciplinary collaborations, with publications in journals like CyberPsychology, Behavior, and Social Networking and Neuroscience and Biobehavioral Reviews . Research interests integrate neuroscience, oncology, and behavioral science, addressing translational challenges in clinical and preclinical settings. His lab explores mechanisms linking inflammation, pain modulation, and cognitive decline in disease contexts.

• Neuroscience
• Cognitive Science
• Pain Management
• +4 more

Maia Kokoeva, PhD, is a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and an Associate Professor in the Department of Medicine, Division of Endocrinology, at McGill University’s Faculty of Medicine and Health Sciences. She leads studies on obesity and neuroendocrine control of energy balance, focusing on leptin sensing and the role of NG2-glia in the hypothalamus. Research Interests: Neuroendocrine regulation of body weight Leptin signaling and sensing mechanisms Hypothalamic circuits controlling energy expenditure NG2-glia biology and adult neurogenesis Genetic mouse models of obesity and diabetes Her recent publications illuminate how NG2-glia in the median eminence mediate leptin entry into the hypothalamus, uncovering new cellular players that could be targeted to prevent age-related weight gain. Laboratory and Affiliations: Dr Kokoeva heads a laboratory within the Metabolic Disorders and Complications Program of the Centre for Translational Biology at RI-MUHC, leveraging state-of-the-art imaging and genetic tools to dissect hypothalamic control of metabolism.

• Obesity
• Energy balance
• Leptin signaling
• +5 more

Mikail Rubinov serves as Assistant Professor of Biomedical Engineering (primary appointment), Computer Science, Psychiatry, and Psychology at Vanderbilt University's School of Engineering. His interdisciplinary work bridges computational neuroscience, network science, and clinical applications. His research focuses on integrative statistical models of large-scale neural data , exploring brain network organization across species and scales. Key interests include evolutionary principles of brain networks, transcriptomic basis of neural individuality, information transfer in neural systems, and neuropsychiatric connectivity phenotypes. The Rubinov Lab develops computational frameworks for analyzing complex neural systems and integrates neuroscientific knowledge with multi-omics data. Recent publications reveal strong trends in network neuroscience methodology development (circular analysis frameworks, unbiased sampling techniques) and translational applications (epilepsy networks, autism spectrum connectomics, gut-brain axis interrogation). His work increasingly incorporates transcriptomic data with neuroimaging at biobank scale. NIH Grant Writing Workshop (June 2022) NIH Workshop Short Talks (April 2023) Rubinov actively mentors graduate and undergraduate students across Biomedical Engineering and Computer Science. His lab maintains collaborations with UCSF, HHMI Janelia Research Campus, Weizmann Institute, and international neuroscience consortia. Current projects include integrative models of large-scale neural data and transcriptomic basis of neural individuality. The Rubinov Lab operates within Vanderbilt's Department of Biomedical Engineering with extensive cross-school collaborations. Technical resources include GitHub repositories for constraint network models (cnm-code), volumetric segmentation (voluseg), and brain connectivity toolboxes.

• Network Neuroscience
• Computational Neuroscience
• Brain Connectivity
• +4 more

Robert Hill is an Associate Professor at Dartmouth College, affiliated with the Biological Sciences department and the Dartmouth Graduate Program in Integrative Neuroscience and Molecular & Cellular Biology. His lab studies neuron-glia interactions focusing on oligodendrocyte development, plasticity, and regeneration in contexts like multiple sclerosis, aging, and Alzheimer's disease. Techniques include high-resolution optical imaging, molecular labels, genetic manipulation, and cellular physiology sensors. Education: B.S. from Trinity College, Ph.D. from University of Connecticut, Postdoctoral Fellow at Yale School of Medicine Research interests span Neuroscience , Developmental Biology , Myelination , and Neurodegenerative Diseases . Recent work explores mitochondrial reorganization in oligodendrocyte generation, CX3CR1-mediated microglial phagocytosis, and age-related myelin plasticity. Scientific awards include the Klingenstein-Simons Fellowship (2022). His lab has received NIH R01 grants (2021, 2025) and seed funding from the Brain Research Foundation (2019). Current lab members include PhD students Zoela Gilani, Kiera Schwarz, and postdoctoral fellows like Yasmine Kamen.

• Neuroscience
• Neurobiology
• Developmental Biology
• +5 more

Jessica A. Mong, PhD , is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine , where she also serves as Assistant Dean for Graduate & Post-Doctoral Studies and Director of Graduate Education for the Program in Neuroscience. Her research focuses on the neuroendocrine mechanisms underlying sex differences in sleep circuitry and the estrogenic modulation of sleep-wake cycles. Primary Appointment: Pharmacology & Physiology Administrative Title: Assistant Dean for Graduate & Post-Doctoral Studies Laboratory Director: Program in Neuroscience Research Interests: Dr. Mong's work investigates how ovarian steroids influence sleep-wake behavior through sexually differentiated neuroanatomical substrates. Key areas include: Mechanisms of estrogenic modulation in the median preoptic nucleus (MnPN) Developmental programming of sex differences in sleep sensitivity Translational studies using rodent and nonhuman primate models of menopause Functional significance of hormonal influences on sleep quality and recovery Scientific Trends: Her recent publications (2023-2025) emphasize: Role of KCNMA1 channelopathy in sleep regulation Adenosinergic signaling in MnPN Translational menopause models Estrogen's protective effects against noise-induced hearing loss Sex-dependent responses to kynurenine pathway challenges Awards & Appointments: NIH BIRCWH Scholar (Building Interdisciplinary Research Careers in Women's Health) Co-Chair, Society for Women’s Health Research Interdisciplinary Research Network on Sex-Differences in Sleep Health NIH/NHLBI R01 HL129138 grant recipient Education & Training: B.S., Biology, Gettysburg College (1987-1991) Ph.D., Neuropharmacology, University of Maryland Baltimore (1994-2000) NIH Postdoctoral Fellowship in Endocrinology, Rockefeller University (2000-2003)

• Neuropharmacology
• Neuroendocrinology
• Sleep Research
• +3 more

Katrina Choe serves as Assistant Professor in the Department of Psychology, Neuroscience & Behaviour at McMaster University and holds a Tier 2 Canada Research Chair in Neurobiology of Social Behaviour. Her research program investigates the multi-level neurobiological mechanisms underlying psychiatric disorders, with primary focus on autism spectrum disorders (ASD) and oxytocin signaling pathways. Her academic training includes: PhD in Neuroscience from McGill University (2013) Honours BSc in Zoology from University of Toronto (2002-2006) Postdoctoral Fellowship at UCLA (2013-2020) Dr. Choe's research employs an integrative approach spanning molecular, cellular, circuit, and network levels to examine how ASD-associated gene mutations disrupt social behavior. Current work centers on oxytocin signaling mechanisms in ASD, convergent neurobiological pathways across psychiatric disorders, and the role of glial cells in neural circuit function. Her lab utilizes advanced techniques including optogenetic fMRI, single-cell RNA sequencing, and multi-level behavioral assays in genetic mouse models. Analysis of her 15 most recent publications reveals a clear research trajectory: early work (2015-2020) established foundational knowledge in vasopressin neuron regulation and salt homeostasis, while recent publications (2022-2025) demonstrate a focused shift toward ASD mechanisms, oxytocin signaling, and social circuit dysfunction using the Cntnap2 knockout model. This evolution reflects her transition from postdoctoral training to independent research leadership. Her scientific recognition includes: Tier 2 Canada Research Chair in Neurobiology of Social Behaviour (2022) NIMH K99/R00 Award CIHR Postdoctoral Fellowship Dr. Choe actively mentors six graduate students across PhD and MSc programs while leading a dynamic research team comprising postdoctoral fellows, laboratory technicians, and undergraduate researchers. Her program receives substantial support from major grants including a 5-year CIHR Project Grant and NSERC Discovery Grant focused on 'The role of CASPR2 in central oxytocin system development.' The Choe Lab maintains active collaborations with leading neuroscience groups including the Bourque, Prager-Khoutorsky, and Cunningham labs, as evidenced by participation in the 4th 1000 Islands/Gananoque Meeting on Hypothalamic Mechanisms. Her laboratory, established in 2020, operates as a multidisciplinary hub utilizing molecular biology (qPCR, RNA-seq), advanced imaging (lightsheet, confocal), electrophysiology (in vitro and in vivo), and behavioral neuroscience approaches to investigate social behavior mechanisms. Current projects examine microglia-astrocyte-neuron interactions in social circuit function and the therapeutic potential of oxytocin for ASD-related social deficits.

• Social Neuroscience
• Autism Spectrum Disorders
• Oxytocin Signaling
• +4 more

Professor James St John is a translational neuroscientist and HTH Dean (Research) at Griffith University, leading the Clem Jones Centre for Neurobiology and Stem Cell Research. His work focuses on developing cell-based therapies for spinal cord injury, leveraging olfactory glial cells and three-dimensional nerve bridges. He holds a PhD in Agricultural Science from the University of Melbourne and has secured over $35 million in research funding. Affiliations: Institute for Biomedicine and Glycomics, Griffith University Roles: Professor, Head of Clem Jones Centre, HTH Dean (Research) Research interests include spinal cord injury repair, peripheral nerve regeneration, microbial contributions to neurodegeneration, and olfactory system biology. His team is advancing a Phase I/IIA clinical trial for spinal cord injury therapy using autologous olfactory cell transplantation combined with rehabilitation. Key grants include Perry Cross Spinal Research Foundation funding ($5M+), NHMRC/MRFF support, and philanthropic donations from the Clem Jones Foundation. Supervised over 30 doctoral and master’s students in neural repair research. Labs/Teams: Clem Jones Centre for Neurobiology and Stem Cell Research, collaborating with Making Strides Rehabilitation for clinical trial readiness.

• Spinal Cord Injury Repair
• Peripheral Nerve Injury
• Neurodegeneration
• +4 more

Dr. David Kang is a Professor in the Department of Pathology at Case Western Reserve University School of Medicine, holding the Howard T. Karsner Professorship in Pathology. He also serves as a VA investigator at the Louis Stokes Cleveland VA Medical Center. Dr. Kang earned his PhD in Neuroscience from UC San Diego in 1999 and has held prior academic roles at UCSD, Seoul National University, and the Byrd Alzheimer’s Institute at USF Health. His research focuses on molecular pathways underlying neurodegenerative diseases, particularly Alzheimer’s disease (AD) and related dementias (ADRDs), including Frontotemporal dementia (FTD), Amyotrophic lateral sclerosis (ALS), and Lewy body disorders (LBD). His interdisciplinary approach employs molecular, biochemical, and imaging techniques, alongside animal models (e.g., mice, C. elegans), to study proteinopathies, mitochondrial dysfunction, and autophagy defects. Key areas include APP processing, autophagy regulation, CHCHD10-mediated pathologies, and exosome-based biomarkers. His work is supported by NIH and VA grants, with a focus on translational strategies to treat or prevent ADRDs. Dr. Kang’s lab investigates mechanisms of neurotoxicity, including Aβ production, tau aggregation, and TDP-43 cytoplasmic inclusions. Recent studies explore SSH1 inhibitors, mitochondrial signaling, and exosome-derived biomarkers for early disease detection. Collaborations with institutions like USF Health and VA hospitals underscore his commitment to bridging basic science and clinical applications.

• Alzheimer's Disease
• Neurodegenerative Disorders
• Proteinopathies
• +3 more

Wilfried O. Rossoll, Ph.D., is an Associate Professor of Neuroscience at Mayo Clinic in Jacksonville, Florida, and serves as Assistant Dean at the Mayo Clinic Graduate School of Biomedical Sciences. He leads the Translational Neuroproteomics Laboratory and is Director of the Multi-Omics Mass Spectrometry Core Laboratory. His research focuses on the molecular mechanisms of protein aggregation in neurodegenerative diseases such as ALS, frontotemporal dementia, and Alzheimer's disease. Ph.D., University of Vienna, Austria Master of Science, University of Vienna, Austria (with research at IMP) Dr. Rossoll's research interests center on understanding proteinopathies—diseases defined by abnormal aggregation of proteins like TDP-43 and tau. His lab uses advanced proteomics, mass spectrometry, and fluorescence microscopy to analyze neuropathological aggregates in human brain tissue and disease models. Key areas include spatial proteomics, molecular profiling of aggregates, mechanisms of protein misfolding, and identifying therapeutic modifiers of aggregation. His work bridges basic science and translational applications, aiming to develop novel therapies for neurodegenerative disorders. The recent publications highlight a strong focus on TDP-43 and tau pathology, phase transitions, stress granule dynamics, and the discovery of nuclear import receptors and other modifiers as therapeutic targets. Techniques such as proximity labeling and spatial proteomics are central to uncovering disease mechanisms and biomarkers. Standing member, Cellular and Molecular Biology of Neurodegeneration Study Section, NIH (2024–present) Associate Editor, Molecular Neurodegeneration (2020–present) Dr. Rossoll has secured multiple research grants from the National Institute on Aging and the U.S. Army, serving as Principal Investigator on projects related to TDP-43 and tau pathology, neuron-glia interactions in Alzheimer's disease, and development of CNTF receptor agonists for ALS therapy. He has mentored postdoctoral fellows and graduate students, contributing to training in neuroscience and proteomics. His laboratory collaborates extensively with the Mayo Clinic Brain Bank and neuropathology teams to validate findings in human tissues. The Translational Neuroproteomics Laboratory operates at the intersection of molecular neuroscience and proteomics, utilizing cutting-edge technologies to decode the composition and dynamics of pathological aggregates. The lab’s work is integral to Mayo Clinic’s broader research mission in neurodegenerative diseases, with a strong emphasis on translating discoveries into clinical applications.

• Neurodegenerative Diseases
• Protein Aggregation
• Neuroproteomics
• +13 more

Skirmantas Janusonis is an Associate Professor in the Department of Psychological and Brain Sciences at the University of California, Santa Barbara (UCSB). He is a core faculty member of the UCSB Neuroscience Research Institute and the Interdepartmental Graduate Program in Dynamical Neuroscience, and a member of the California NanoSystems Institute. His research program lies at the intersection of neuroscience, complex systems, and computational modeling. Education: Ph.D. in Neuroscience and Behavior, University of Massachusetts Amherst Postdoctoral Research, Department of Neuroscience, Yale University School of Medicine B.S./M.S. in Biology, Vilnius University, Lithuania Dr. Janusonis's research focuses on the stochastic (random walk-like) behavior of serotonergic axons in the brain, particularly within the ascending reticular activating system and the broader serotonergic matrix. His work integrates molecular neurobiology, comparative neuroanatomy (from sharks to rodents to humans), advanced microscopy, and supercomputing simulations. He investigates how these complex systems self-organize and their relevance to mental disorders, especially autism and the enigma of platelet hyperserotonemia. His lab collaborates with physicists, mathematicians, and engineers to model anomalous diffusion and fractional Brownian motion in 3D brain spaces. His recent publications reveal a strong trend toward computational and theoretical neuroscience, using high-resolution data and mathematical generalizations to model axonal distributions. Key themes include reflected fractional Brownian motion, self-organization of serotonergic densities, and the interface between central and peripheral serotonin systems. His work challenges traditional views of the blood-brain barrier and proposes interdisciplinary solutions involving immunology, physiology, and computer science. Scientific Awards and Recognition: Elected to the Board of Directors of the Organization for Computational Neurosciences (2024) NSF, NIMH, and California NanoSystems Institute grant funding Multiple student awards under his mentorship, including the Harry J. Carlisle Award and NIH IRTA NSF CRCNS and Frontera supercomputing grants UCSB Art of Science People's Choice Award (awarded to lab member) Dr. Janusonis actively mentors PhD students such as Justin Haiman and Dahyana Arroyo, and has advised alumni including Dr. Angela Chen, Dr. Kasie Mays, and Dr. Melissa Hingorani. His lab has received numerous grants from the NSF and NIH, supporting research on stochastic axon systems and super-resolution imaging. He teaches graduate and undergraduate courses including Neuroanatomy (Psy 269), Neurobiology of Brain States (Psy 136), and Complex Systems (Psy 113L). Research Team and Collaborations: The Janusonis Lab is an interdisciplinary group combining neuroscience, mathematics, and engineering. It collaborates with institutions such as UC San Diego, the University of Pisa, and MIT. The lab is equipped with advanced imaging tools and has access to Frontera, a leading NSF supercomputer. Outreach includes science nights at local schools and public lectures at the Santa Barbara Museum of Natural History.

• Computational Neuroscience
• Molecular, Cellular & Circuit Mechanisms
• Dynamical Neuroscience
• +12 more